Company Summary
Search
Home Page
 
IBEX Technologies Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
July 31TradingN
Board of Directors
NamePosition
Bernard R. Patriacca  Director of the Board
Danilo Netto  Director of the Board
Paul Baehr  Chairperson of the Board
  Director of the Board
  President/CEO & Interim Director of Finance
Robert DeLuccia  Director of the Board
Robert Heft  Director of the Board
Thomas O. Hecht  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
10/Apr/1972  Canada   
Exchange Filing Office
Location
Montreal Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Biotechnology/Biopharmaceutical  ABOUT IBEX (From News Release July 3, 2013) The Company, through its wholly owned subsidiaries, IBEX Pharmaceuticals Inc. (Montreal, QC) and Bio-Research Products Inc. (North Liberty, IA), manufactures and markets enzymes for biomedical use. IBEX also manufactures and markets a series of arthritis assays which are widely used in osteoarthritis research.  
Securities
SymbolSecurity NameMarketStatus
IBTIBEX Technologies IncTSX VentureTRADING
Name HistoryFromTo
IBEX Technologies Inc.19/Dec/2007Present
Company Facts Reconciliation
SubjectDate Returned
Fall 2014 CFRNot Received
Associations
Auditing Firm:  PricewaterhouseCoopers LLP
Law Firm:  Heenan Blaikie
Subsidiary:  IBEX Pharmaceuticals Inc.
Transfer Agent:  CST Trust Company
Latest Information
TypeDateTitle
News Releases  30/Sep/2014  NEWS RELEASE - IBEX PROVIDES UPDATE ON GARVINCI SUIT[MARKETWIRE]
    NEWS RELEASE - UPDATE ON GARVINCI SUIT[MARKET NEWS]
    NEWS RELEASE - IBEX REPORTS RESULTS FOR THE THIRD QUARTER AND T[MARKET NEWS]
Bulletins  22/Jan/2013  Property-Asset or Share Purchase Agreement
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data